At the virtual DTx East conference in September, five active investors with a focus on digital therapeutics discussed the market. Here are four of the topics they dug into:
- What they look for in potential investment targets
- Red flags when evaluating a digital therapeutic startup
- What startups should look for in investors
- How COVID--19 has just been a speedbump for some and created tailwinds for others
- And more...
Here are the panelists and notes from their self-introductions:
Caleb Winder, Managing Director, MemorialCare Innovation Fund
We are focused on investing in healthcare companies across the US in early Series B or later.
Chihiro Hosoya Head of Venture Management & Business Development, Rx+ Business Accelerator Astellas Pharma
Astellas is a pharmaceutical company based in Japan but we operate globally. My scope includes both digital and devices, so we are super interested in